Use of chalcones for the treatment of viral disorders

Details for Australian Patent Application No. 2006251668 (hide)

Owner Galileo Pharmaceuticals, Inc. Johnson & Johnson Consumer Companies, Inc.

Inventors Boddupalli, Sekhar; Saliou, Claude; Mahmood, Khalid

Agent Shelston IP

Pub. Number AU-B-2006251668

PCT Pub. Number WO2006/127539

Priority 11/137,198 24.05.05 US

Filing date 19 May 2006

Wipo publication date 30 November 2006

Acceptance publication date 2 February 2012

International Classifications

A61P 31/22 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

20 December 2007 PCT application entered the National Phase

  PCT publication WO2006/127539 Priority application(s): WO2006/127539

2 February 2012 Application Accepted

  Published as AU-B-2006251668

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006251674-System for automatically distributing a trading order over a range of prices

2006251660-Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes